Key Insights: Ripple’s native cryptocurrency XRP has once again grabbed the limelight amid the broader crypto market recovery. Experts cite a multi-year breakoutKey Insights: Ripple’s native cryptocurrency XRP has once again grabbed the limelight amid the broader crypto market recovery. Experts cite a multi-year breakout

XRP Price Eyes Multi-Year Breakout to $50, But This Major Hurdle Remains

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Insights:

  • Crypto analyst Crypto Patel is very much bullish about the XRP price action and sees potential upside from here.
  • Analyst Doctor Profit said XRP’s RSI has reached extreme oversold levels similar to the December 2022 market bottom.
  • Legal expert Bill Morgan said labeling XRP as a financial product could hinder its efficiency as a fast, low-cost bridge currency.

Ripple’s native cryptocurrency XRP has once again grabbed the limelight amid the broader crypto market recovery.

Experts cite a multi-year breakout for XRP price and RSI indicators in oversold territory that suggests major upside ahead. However, Ripple faces a major challenge of whether or not to bring XRP in mainstream finance.

XRP Price Stares At Multi-Year Breakout

Crypto analyst Crypto Patel said that XRP has confirmed a multi-year triangle breakout on the technical chart. This signals the potential for a major upside move in the next market cycle.

Patel identifies a breakout pattern in XRP’s chart. He measures the move and projects a long-term target. He sets that target at around $50 in the next bull run.

XRP price chart breakout | Source: Crypto Patel, XXRP price chart breakout | Source: Crypto Patel, X

The analyst also noted that he previously highlighted an XRP price entry zone near $0.50 in 2024. Patel noted the token’s rally. He said it climbed to about $3.66. He emphasized that this marked a strong surge. He highlighted it as nearly a 7x return from that level.

XRP Price Slips in Undervalued Zone

Crypto analyst Doctor Profit said that XRP may be significantly undervalued based on current technical indicators.

The analyst noted that XRP’s Relative Strength Index (RSI) has dropped to extreme oversold levels. That’s similar to the market bottom in December 2022. According to Doctor Profit, a buy signal was issued near the $1.37 level.

XRP RSI levels in oversold territory | Source: Crypto PatelXRP RSI levels in oversold territory | Source: Crypto Patel

ChartNerd counters Patel’s view. He argues the XRP price won’t surge right away. He stresses that the upside will take time.

Source: XSource: X

He believes patience is essential before the next move. He noted that the Ripple cryptocurrency could first drop to $0.7-$0.8 before recovering.

XRP’s Mainstream Adoption Can Create Hurdles

Bill Morgan cautions against regulatory overreach. He warned that labeling XRP as a financial product could hurt its ecosystem. He stressed that such classification may create operational disadvantages for the technology behind it.

Morgan stated that strict financial product rules could weaken XRP’s utility. He explained that such regulations may slow its speed, and warned that they could raise costs.

He stressed this would reduce XRP’s effectiveness as a bridge currency for cross-border payments. He argued that additional compliance requirements could reduce network efficiency.

The lawyer also pointed out that the definition of a “financial product” varies across jurisdictions. Morgan noted that regulators in Japan and Australia have taken different approaches to crypto regulation. He wrote:

U.S. regulators are stepping up collaboration. The SEC and CFTC agreed to coordinate oversight of digital assets. They aim to streamline rules and reduce regulatory overlap. This move signals a more unified approach to crypto regulation.

The post XRP Price Eyes Multi-Year Breakout to $50, But This Major Hurdle Remains appeared first on The Market Periodical.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Share
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26